Market Cap : 60.6 B | Enterprise Value : 69.65 B | PE Ratio : 72.98 | PB Ratio : 3.51 |
---|
NYSE:BSX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:BSX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2022-08-13), Boston Scientific's share price is $42.33. Boston Scientific's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2022 was $0.83. Hence, Boston Scientific's Price-to-Operating-Cash-Flow Ratio for today is 50.94.
The historical rank and industry rank for Boston Scientific's Price-to-Operating-Cash-Flow or its related term are showing as below:
During the past 13 years, Boston Scientific's highest Price-to-Operating-Cash-Flow Ratio was 183.35. The lowest was 5.75. And the median was 29.24.
Boston Scientific's Cash Flow from Operations per share for the three months ended in Jun. 2022 was $0.21. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2022 was $0.83.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Boston Scientific was -47.00% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 80.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 12.10% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 2.90% per year.
During the past 13 years, Boston Scientific's highest 3-Year average Operating Cash Flow per Share Growth Rate was 108.10% per year. The lowest was -33.20% per year. And the median was 2.30% per year.
The historical data trend for Boston Scientific's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Boston Scientific's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Boston Scientific's Price-to-Operating-Cash-Flow falls into.
Boston Scientific's Price-to-Operating-Cash-Flow ratio for today is calculated as
Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
= | 42.33 | / | 0.831 | |
= | 50.94 |
Boston Scientific's Share Price of today is $42.33.
Boston Scientific's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.83.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Price-to-Operating-Cash-Flow Ratio | = | Market Cap | / | Cash Flow from Operations |
Thank you for viewing the detailed overview of Boston Scientific's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Wichmann David S | director | UNITEDHEALTH GROUP INC 9900 BREN RD E MINNETONKA MN 55343 |
Brown Vance R | officer: SVP, GC and Corp. Secretary | C/O BOSTON SCIENTIFIC CORPORATION 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752 |
Olson Scott | officer: SVP & Pres, Rhythm Management | C/O BOSTON SCIENTIFIC CORPORATION 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752 |
Scanlon Meghan | officer: SVP,Pres,Urology Pelvic Health | C/O BOSTON SCIENTIFIC CORPORATION 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752 |
Monson Jonathan | officer: VP, Corp Controller and CAO | C/O BOSTON SCIENTIFIC CORPORATION 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752 |
Fujimori Yoshiaki | director | 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752 |
James Donna | director | ONE MIRANOVA PLACE SUITE 1040 COLUMBUS OH 43215 |
Zane Ellen M | director | C/O TUFTS-NEW ENGLAND MEDICAL CENTER 750 WASHINGTON STREET, TUFTS-NEMC #451 BOSTON MA 02111 |
Sununu John E | director | C/O BOSTON SCIENTIFIC CORPORATION 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752 |
Connors Nelda J | director | BOSTON SCIENTIFIC CORPORATION 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 |
Ludwig Edward J | director | C/O BECTON DICKERSON & CO 1 BECTON DR FRANKLIN LAKES NJ 07417 |
Roux David J | director | C/O BOSTON SCIENTIFIC CORPORATION 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752 |
Dockendorff Charles J | director | COVIDIEN LTD. 15 HAMPSHIRE STREET MANSFIELD MA 02048 |
Macmillan Stephen P | director | 250 CAMPUS DRIVE MARLBOROUGH MA 01752 |
Wang Xin Warren | officer: SVP and Pres, Asia Pacific | C/O BOSTON SCIENTIFIC CORPORATION 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752 |
From GuruFocus
Other Sources
By Zacks 2021-12-23
By Zacks 2022-01-26
By tipranks.com 2022-02-11
By Zacks 2022-02-02
By Zacks 2022-02-01
By Zacks 2021-11-10
By Seekingalpha 2022-01-31
By Zacks 2022-03-04
By Zacks 2021-10-28
By Zacks 2021-12-16
By Zacks 2022-02-02